Inactive Instrument

Official Publications THERACLION N Euronext Paris

Equities

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

03-27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Combined general shareholders meeting	05-12	CO
Financial report	04-24	CO
Annual results	03-26	CO
Annual results	03-26	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	01-31	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	01-29	CO
4th quarter turnover	01-28	CO
4th quarter turnover	01-28	CO
Monthly statement on voting rights	12-30	CO
Monthly statement on voting rights	11-29	CO
Monthly statement on voting rights	30/10/23	CO
Half-year report	29/10/23	CO
1st-half-year results	10/10/23	CO
1st-half-year results	10/10/23	CO
Monthly statement on voting rights	29/09/23	CO
Monthly statement on voting rights	30/08/23	CO
Monthly statement on voting rights	30/07/23	CO
Minutes of the general assembly	28/06/23	CO
Admission of new securities	21/06/23	CO
Admission of new securities	21/06/23	CO
Mixed general Shareholders meeting notice	13/06/23	CO
Monthly statement on voting rights	30/05/23	CO
Changes in management and corporate officers	24/05/23	CO
Changes in management and corporate officers	24/05/23	CO
Combined general shareholders meeting	23/05/23	CO